Risk of thyroid cancer in women treated for infertility

Česká verzia

Authors: Květuše Vošmiková; Dana Nováková; Martin Křenek; Pavla Sýkorová; Petr Vlček
Authors place of work: Klinika nukleární medicíny a endokrinologie 2. LF UK a FN Motol, Praha
Published in the journal: Prakt Gyn 2016; 20(1): 15-18
Category: Oncogynecology: Review Article

Summary

Thyroid cancer is a disease in which in recent years have seen a large increase in incidence, both globally and in the Czech Republic. This disease affects significantly more women. Among patients in our clinic, we recorded 22 women with differentiated thyroid carcinomas covered during the previous period, a treatment for infertility using methods of assisted reproductive technology. For one of the patients was a follicular carcinoma, the other twenty-one patients were present papillary carcinoma. We present our group, we report cases of some patients. We also describe risk factors for thyroid cancer, mainly the relationship of the tumor to reproductive factors.

Key words:
assisted reproductive technology – in vitro fertilization – thyroid carcinoma

Zdroje

1. Nováková D, Křenek M, Vošmiková K et al. Rizikové faktory vzniku karcinomu štítné žlázy (Risk factors of thyroid carcinoma). Vnitr Lek 2015; 61(7–8): 655–659.

2. Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer 2014; 21(5): T273-T283.

3. Fiore E, Rago T, Provenzale MA et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010; 17(1): 231–239.

4. Konturek A, Barczyński M, Wierzchowski W et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg 2013; 398(3):389–394.

5. Reigstad MM, Larsen IK, Myklebust TÅ et al. Cancer risk among parous women following assisted reproductive technology. Hum Reprod 2015; 30(8): 1952–1963.

6. Brinton LA, Moghissi KS, Scoccia B et al. Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril 2015; 104(4): 980–988.

7. Caini S, Gibelli B, Palli D et al. Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies. Cancer Causes Control 2015; 26(4): 511–518.

8. Wang P, Lv L, Qi F et al. Increased risk of papillary thyroid cancer related to hormonal factors in women. Tumour Biol 2015; 36(7): 5127–5132.

9. Zamora-Ros R, Rinaldi S, Biessy C et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. I Int J Cancer; 136(5): 1218–1227.

10. Hannibal CG, Jensen A, Sharif H et al. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 2008; 23(2): 451–456.

11. Zhu J, Zhu X, Tu C et al. Parity and thyroid cancer risk: a meta-analysis of epidemiological studies. Cancer Med 2015 Dec 29. Dostupné z DOI: <http://dx.doi.org/10.1002/cam4.604>.

12. Pazaitou-Panayiotou K, Toulis KA, Mandanas S et al. Thyroid cancer after in vitro fertilization: a retrospective, non-consecutive case-series analysis. Gynecol Endocrinol 2014; 30(8) : 569–572.

13. Lukas J, Drabek J, Lukas D et al. The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157(3): 266–275.